Agile Therapeutics, Inc. (AGRX) earnings
Quarterly and annual AGRX reports and results, each read against the price at its own news timestamp. Back to the AGRX overview →
9 measured AGRX earnings events.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q AGILE THERAPEUTICS INC For: Jun 30 | SEC filing · Form 10-Q | +0.00% | +0.69% | |
| Agile Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update | Press release | +0.30% | +5.46% | |
| Form 10-Q AGILE THERAPEUTICS INC For: Mar 31 | SEC filing · Form 10-Q | +0.30% | +5.46% | |
| Form 10-K/A AGILE THERAPEUTICS INC For: Dec 31 | SEC filing · Form 10-K | +0.00% | +3.97% | |
| Form 10-K AGILE THERAPEUTICS INC For: Dec 31 | SEC filing · Form 10-K | +0.30% | -18.55% | |
| Agile Therapeutics Posts Growth In Third Quarter Results, Reiterates Confidence In Target of $25M Net Revenue, Positive Cash Flow In 2024 | Press release | — | -3.29% | |
| Agile Therapeutics Reports Third Quarter 2023 Financial Results and Provides Corporate Update | Press release | +0.50% | +2.50% | |
| Form 10-Q AGILE THERAPEUTICS INC For: Sep 30 | SEC filing · Form 10-Q | +0.89% | -5.66% | |
| Agile Therapeutics to Report Third Quarter 2023 Financial Results and Provide Business Update on Thursday, November 9, 2023 | Press release | +0.54% | -1.63% |
Keep exploring
More AGRX: analyst actions → · SEC filings → · AGRX overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Organovo Holdings, Inc. (ONVO) | 87 | -0.95% | 37% |
| Flurotech Ltd (TEST_CDNX) | 87 | 0.00% | 41% |
| INTEGRATED BIOPHARMA INC (INBP) | 86 | 0.00% | 45% |
| NORTHWEST BIOTHRPUTCS INC (NWBO) | 86 | -0.49% | 41% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.